Oncology Practice (@oncologypractic) 's Twitter Profile
Oncology Practice

@oncologypractic

MDedge Hematology & Oncology brings together the resources of Oncology Practice, JCSO, Hematology News, and Hematology Times.

ID: 389600255

linkhttp://www.mdedge.com/oncologypractice calendar_today12-10-2011 17:59:06

2,2K Tweet

1,1K Takipçi

479 Takip Edilen

Oncology Practice (@oncologypractic) 's Twitter Profile Photo

Failure to disclose speaking fees, grants, and research payments was common among investigators involved with #oncology drug trials. mdedge.com/oncologypracti…

Failure to disclose speaking fees, grants, and research payments was common among investigators involved with #oncology drug trials.  mdedge.com/oncologypracti…
Sharon Worcester (@sw_medreporter) 's Twitter Profile Photo

Conference organizers: Practice-changing research findings abound at 19th World Conference on Lung Cancer! Watch for my coverage at MDedge.com, OncologyPractice.com #WCLC2018

Sharon Worcester (@sw_medreporter) 's Twitter Profile Photo

Oncogene-driven patient groups are driving a new era for research partnerships, accelerating new research! Watch for coverage @ MDedge.com, oncologypractice.com #WCLC2018

Oncogene-driven patient groups are driving a new era for research partnerships, accelerating new research! Watch for coverage @ MDedge.com,  oncologypractice.com #WCLC2018
Sharon Worcester (@sw_medreporter) 's Twitter Profile Photo

Phase 2 data in locally advanced, potentially resectable NSCLC: combined chemo/immunotherapy, known to be of benefit for metastatic NSCLC, shows "promising antitumor activity, unprecedented complete pathologic response rate" in neoadjuvant setting. #WCLC2018

Sharon Worcester (@sw_medreporter) 's Twitter Profile Photo

CheckMate 227: advanced NSCLC patients with high tumor burden report better experience with nivolumab + ipilimumab vs. chemotherapy. Watch for my coverage at MDedge.com, oncologypractice.com. #WCLC2018

CheckMate 227: advanced NSCLC patients with high tumor burden report better experience with nivolumab + ipilimumab vs. chemotherapy. Watch for my coverage at MDedge.com, oncologypractice.com.  #WCLC2018
Oncology Practice (@oncologypractic) 's Twitter Profile Photo

#CT screenings can reduce lung cancer deaths. Findings reported at #WCLC2018 show it can reduced lung cancer deaths by 26% at 10 years. Here is the latest: mdedge.com/oncologypracti… #lungcancer #cancer #mdedge #medicalnews #medicine

#CT screenings can reduce lung cancer deaths. Findings reported at #WCLC2018 show it can reduced lung cancer deaths by 26% at 10 years. 

Here is the latest: mdedge.com/oncologypracti…

#lungcancer #cancer #mdedge #medicalnews #medicine
Oncology Practice (@oncologypractic) 's Twitter Profile Photo

Get ready for high-sensitivity troponin tests in the ED. Richard Nowak warns on cutoff values #ACEP18 mdedge.com/emed-journal/a…

Vascular Surgery (@survascular) 's Twitter Profile Photo

Subscribe with : …calpathology.pathologyconferences.com Get all the details on "Recently characterized soft tissue tumors that bring biologic insight" & befold greatest event in #ThoracicPathology #EndocrinePathology #PulmonaryPathology #NephroPathology Independent Oncology Oncology Practice

Subscribe with : …calpathology.pathologyconferences.com
Get all the details on "Recently characterized soft tissue tumors that bring biologic insight" &amp; befold greatest event in #ThoracicPathology #EndocrinePathology  #PulmonaryPathology #NephroPathology <a href="/IndOncology/">Independent Oncology</a> <a href="/OncologyPractic/">Oncology Practice</a>
Christine Simmons (@drcesimmons) 's Twitter Profile Photo

Did I just hear that correctly Dr. Noah Federman? ORR of 93% to Larotrectinib in patients with #sarcoma with NTRK gene fusion! #CTOS2018

Did I just hear that correctly Dr. Noah Federman?  ORR of 93% to Larotrectinib in patients with #sarcoma with NTRK gene fusion!  #CTOS2018
Oncology Practice (@oncologypractic) 's Twitter Profile Photo

#Oncology Practice is joining #Hematology News and Hematology Times to bring you MDedge Hematology & Oncology. MDedge Hematology & Oncology brings evidence-based, practice-changing information. #MDedge: Keeping You Informed. Saving You Time.

#Oncology Practice is joining #Hematology News and Hematology Times to bring you MDedge Hematology &amp; Oncology. <a href="/MDedgeHemOnc/">MDedge Hematology & Oncology</a> brings evidence-based, practice-changing information. #MDedge: Keeping You Informed. Saving You Time.
MDEdge (@mdedgetweets) 's Twitter Profile Photo

Dear #medstudents, The big day is tomorrow. As you anxiously await your #MATCHDAY2019 results with your friends and family near, take a minute and remind yourself why you made such a huge step in life. We commend and appreciate you. #Getreadytochangetheworld #MDedge

MDEdge (@mdedgetweets) 's Twitter Profile Photo

As #MatchDay2019 celebrations continue, #MDedge is highlighting the #Top10 twitter posts of #2019, by Priyanka V. Chugh MD, MS, @DannyYanny, Riley Lochner, @AnitaKnopov, Y. Jay Lin, @OlatunjiMD19, @_BenRoush, @StephanieAAFP, Esté Ginelle & Dr. Kendra, MD. Congratulations! #matchweek

MDEdge (@mdedgetweets) 's Twitter Profile Photo

We would love to network with you. Follow #MDedge on LinkedIn today! #networking #hcsm #FF #linkedin #medicalnews #health #healthcare #journalism

MDEdge (@mdedgetweets) 's Twitter Profile Photo

Today on #NationalDoctorsDay, we honor and appreciate all #doctors. You impact and change the lives of #patients every day and your #compassion and tireless #dedication bring #comfort around the world. #MDedge Thank you to Riley Children's, University of Nebraska Medical Center, UNM Health Sciences and others.

Oncology Practice (@oncologypractic) 's Twitter Profile Photo

Always remembering the brave men and women who paid the ultimate sacrifice for our freedom. Thank you for your service. #MemorialDay2019

Always remembering the brave men and women who paid the ultimate sacrifice for our freedom. Thank you for your service.  #MemorialDay2019